NRP2 and central nervous system cancer: One study supports that Nrp2 expression is low in both low- and high-grade gliomas [86] while another study suggests that Nrp2 is expressed highly in 37% of glioblastoma and that its concomitant overexpression with VEGF-C correlates with poor patient survival [87].